BioSTL
BioSTL is a St. Louis-based nonprofit founded in 2001 that builds the regional bioscience innovation ecosystem through BioGenerator's early-stage capital and lab facilities, BioSTL Global's international soft-landing programs, summits, and workforce training serving startups, healthcare systems, ag corporations, and research institutions.
- Company typePrivate
- Founded2001
- HeadquartersSt Louis, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What BioSTL does
BioSTL is a St. Louis-based 501(c)(3) nonprofit (EIN: 45-2137574) founded in 2001 that functions as a regional bioscience innovation ecosystem builder rather than a product technology company. The organization convenes researchers, entrepreneurs, healthcare systems, ag corporations, farmers, and investors into a single coordinated cluster centered on St. Louis' Cortex Innovation District and 39 North / Helix Center, leveraging 25 years of accumulated coalition capital. Its core operating subsidiaries are BioGenerator (the startup investment and company-building arm, with over $50M deployed across 140+ ventures whose portfolio has attracted $2.8B-$3B from 200+ global investors at greater than 60X leverage) and BioSTL Global (the international partnership and soft-landing arm). BioSTL does not develop proprietary technology products; its "platform" is a coordinated portfolio of programs covering the full startup lifecycle, including BioGenerator Labs (shared lab facilities that have hosted 200+ companies), Startup Connect (invite-only investor conference), the Healthcare Buyer Platform (curated BD meetings representing $550B+ in purchasing power), Innovators Hour (monthly founder storytelling), BIOTECH for MO (workforce training targeting 350 individuals), the Venture Fellows program, NEURO360, EAGIC (farmer trial network), Global AgXelerate (India-US agtech gateway), the Global Health Innovation Summit, the Global AgriFood Innovation Summit, the inaugural Breakthrough Gala, and Cultivar STL (Latin American startup access fund).
BioSTL's revenue model is a mix of philanthropic giving (individual, corporate, and foundation donations via cash, DAFs, stock, QCDs, and bequests), event sponsorships (multi-tier packages for the annual Breakthrough Gala and summits), government and foundation grants (e.g., $2M from Missouri DED for BIOTECH for MO; historical $1.5M-$30M grants from EDA, Bayer, and JP Morgan Chase), and BioGenerator's equity-linked investment activity across the human health and agriculture portfolio. Programs and services are offered to ecosystem participants at no direct cost. Customers and partners span large enterprise health systems (BJC HealthCare, SSM Health, Ascension, Mercy, Evernorth/Cigna, Centene), global agrifood majors (AB InBev, ADM, Bayer, Bunge, Nestle Purina, Post, Burger King), research institutions (Washington University, Donald Danforth Plant Science Center), national commodity and farm bureau organizations, and 140+ portfolio startups spanning cell therapy, diagnostics, ag biotech, geospatial, and applied AI.
Geographically, BioSTL operates as a St. Louis-headquartered organization with formal international reach into the UK (via NHS Health Innovation Networks and Yorkshire & Humber), India (via AgVaya), Latin America (via Cultivar STL, Embrapa, ARISE), and Rwanda (emerging economic partnership commentary), funded by a UK government grant for ARISE. Go-to-market is community-led and event-driven: a calendar of summits, galas, investor conferences, and curated BD meetings serves as the primary demand-generation and partnership-formation mechanism, anchored by content marketing, newsletters (The Sequence), a YouTube channel, LinkedIn presence, and a podcast.
BioSTL firmographics
Firmographics- Name
- BioSTL
- Legal name
- BioSTL
- Website
- https://biostl.org
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioSTL is a St. Louis-based nonprofit founded in 2001 that builds the regional bioscience innovation ecosystem through BioGenerator's early-stage capital and lab facilities, BioSTL Global's international soft-landing programs, summits, and workforce training serving startups, healthcare systems, ag corporations, and research institutions.
- Ownership category
- akta.pro rank
BioSTL industry classification
Industry- Product category
- Bioscience Innovation Ecosystem Development
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000), Agricultural Services (700)
- akta.pro primary industry
- Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
- akta.pro secondary industry
- Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF)
Keywords
Where BioSTL is headquartered
LocationHeadquarters
- HQ city
- St Louis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioSTL business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others, Infrastructure
Revenue model
- Donations and Philanthropic Support: As a 501(c)(3) nonprofit organization (EIN: 45-2137574), BioSTL relies on charitable donations from individuals, corporations, and foundations. Contributions are tax-deductible to the extent allowed by law. The organization accepts cash/check donations, gifts through Donor-Advised Funds (DAF), gifts of stock, Qualified Charitable Distributions from IRAs, and legacy/bequest gifts.
- Gala and Event Sponsorships: The annual Breakthrough Gala and other events generate sponsorship revenue from corporate sponsors at various tiers (Premier, Diamond, Gold, Silver, Bronze). Sponsors receive recognition and benefits based on their contribution level.
- BioGenerator Investment Returns: BioGenerator, BioSTL's startup investment arm, generates returns through equity investments in early-stage bioscience companies. BioGenerator has invested over $50 million in startups and portfolio companies have raised $3 billion from investors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Annual | Breakthrough Gala ticket purchases available for purchase |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels6 records
BioSTL product offering
Product offeringCore offering
BioSTL is a 501(c)(3) nonprofit that builds and convenes the St. Louis bioscience innovation ecosystem. Through its investment arm BioGenerator, it provides catalytic early-stage capital, lab space, and company-building resources to life sciences startups in human health and agriculture. It also runs international soft-landing programs (BioSTL Global, Global AgXelerate), workforce training (BIOTECH for MO, Venture Fellows), and convenes flagship annual events (Global Health Innovation Summit, Global AgriFood Innovation Summit, Breakthrough Gala, Startup Connect).
Product overview
BioSTL is a nonprofit bioscience innovation organization that functions as an ecosystem builder rather than a product company in the traditional sense. Its offering is a coordinated portfolio of programs and services that support the full lifecycle of bioscience startup creation and growth. The core investment and company-building arm is BioGenerator Ventures (including BioGenerator Labs for lab facilities), which is supplemented by a rich calendar of convening programs including Innovators Hour (monthly founder storytelling sessions), Startup Connect (annual invite-only investment conference), Breakthrough Gala (annual fundraising event), Global AgriFood Innovation Summit (annual agriculture innovation conference), and Global Health Innovation Summit (annual healthcare innovation conference). Supporting programs include the BIOTECH for MO statewide workforce training initiative, the Early Adopter Grower Innovation Community (EAGIC) connecting agtech startups with trial farms, Global AgXelerate (international agtech soft-landing program), Venture Fellows Program (training scientists in entrepreneurship), and NEURO360 (neuroscience hub initiative). These programs collectively cover startup acceleration, capital investment, talent development, workforce training, international market access, and convening — forming a comprehensive innovation ecosystem.
Differentiator
Problem solved
Functional benefit
Products and services
- BioGenerator Ventures
Quantifiable outcome
- Over $50M invested in 140+ early-stage startups, with portfolio companies raising $3B from 200+ global investors (60X leverage)
- +5 more outcomes
Companies that use BioSTL
Customer profileNamed customers16 records
Ideal customer profiles6 records
BioSTL technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioSTL partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered core and minor.
- NHS Health Innovation Networks (UK)coreBioSTL Global signed an agreement with the UK's National Health Service Health Innovation Networks to establish St. Louis as a gateway for British digital health startups entering the U.S. market. The partnership connects UK innovators with St. Louis' $500 billion healthcare ecosystem for pilots, licensing, and commercial scaling of AI and digital health technology.
- Health Innovation Yorkshire & HumbercoreSigned a collaboration agreement to support health and life sciences businesses in the Yorkshire and Humber region. The partnership provides access to BioSTL's network of investors, healthcare providers, research institutions, and industry partners, including joint trade missions, mentorship, and knowledge-sharing activities aimed at helping innovators expand internationally.
- Agri-TechEcorePartner in the ARISE (AgriTech for Resilience, Innovation & Sustainable Ecosystems) initiative, a trilateral platform connecting science, technology, and investment ecosystems across the UK, US, and Latin America through capability mapping, startup evaluation, and knowledge exchange.
- Embrapa (Brazil)corePartner in the ARISE initiative, connecting Brazilian agricultural research capabilities with UK and US innovation ecosystems for food security and sustainable agriculture collaboration.
- Agri TIERR AcorePartner in the ARISE initiative focused on strengthening international cooperation around food security and sustainable agriculture through research, commercial, and farmer partnerships.
- World Trade Center St. LouisminorPartner in ARISE initiative, with relationship-building efforts dating back to 2017 supporting international trade and delegation visits including the ARISE cohort visiting St. Louis in February 2026.
- Donald Danforth Plant Science CentercoreThe Donald Danforth Plant Science Center administers the Core Facilities Access Fund, an initiative of Cultivar STL designed to help Latin American startups access US markets via world-class plant science facilities. Breakthrough Energy Discovery supports the fund.
- AgVaya LLP (India)coreLaunched Global AgXelerate, a new international collaboration platform designed to connect agriculture innovators, startups, and industry leaders with opportunities to establish their US base in St. Louis. The partnership was officially launched at the seminar 'Innovations for Regenerative Agriculture – Indian and Global Experiences' in New Delhi.
- The Yield Lab InstitutecorePartner in the Cultivar STL initiative and Core Facilities Access Fund selection committee. A agrifood think tank and ecosystem connector headquartered in St. Louis, non-profit affiliate of The Yield Lab Group.
- ReACH Coalition Members (AB InBev, ADM, Bayer, Bunge, Burger King, Donald Danforth Plant Science Center, Growmark, ICL, Illinois Farm Bureau, Missouri Farm Bureau, National Corn Growers Association, Nestlé Purina, Post, Taylor Geospatial Institute, United Soybean Board, Gates Ag One, Washington University, 39 North)coreThe ReACH (Regenerative Agrifood Coalition in the Heartland) is a collaboration of regional food and agriculture corporations, farmers, national commodity organizations, research institutions and farm bureaus representing the entire ag value chain. Coalition members leverage global innovation to build a more sustainable agrifood system.
- NEURO360 Partnership Network (50+ organizations)coreNEURO360, led by WashU and BioSTL, has assembled a neurotechnology network with over 50 organizations contributing more than $60 million in resources. Despite not being selected for NSF Engines grant, the initiative continues to foster a robust neuroscience innovation ecosystem in St. Louis.
- Jackie Joyner-Kersee FoundationminorPartnership in opening an innovation center focused on growing St. Louis' bioscience talent pipeline. Represents BioSTL's workforce development and talent pipeline building efforts in the community.
- BJC HealthCarecoreKey healthcare system partner in BioSTL's Global Health Innovation Summit and Healthcare AI Collaborative. Represented at the $550B+ Healthcare Buyer Platform. BJC/WashU Innovation Center is a major healthcare innovation hub in St. Louis.
- SSM HealthcoreMajor health system partner in BioSTL's healthcare innovation ecosystem. $11.4B revenue from 23 hospitals across 4 states. Key participant in Global Health Innovation Summit.
- AscensioncoreLargest non-profit hospital system in USA with $27.2B revenue from 151 hospitals across 22 states. Key buyer participant in BioSTL's healthcare innovation programs.
- Evernorth / CignacoreLeading Health Service Company combining payer and PBM capabilities with $212B in revenue. Participant in BioSTL's Healthcare Buyer Platform connecting innovators with major healthcare purchasers.
- CentenecoreLargest Medicaid & Exchange Managed Care Company in USA with $154B in revenue across 50 states. Key payer partner in BioSTL's healthcare innovation initiatives.
Scale indicators12 records
Recent moves6 records
Expansion highlights6 records
BioSTL competitors and assessment
Company assessmentDirect peers
- Biocom: California's largest life-science industry association, advocating for and convening biotech companies, investors, and research institutions across San Diego, San Francisco, Los Angeles, and Washington DC. Directly comparable to BioSTL as a regional bioscience ecosystem builder with policy advocacy, capital access, and event programs.
- MassBio: Massachusetts Biotechnology Council is the leading bioscience industry association for the Boston/Cambridge cluster, providing networking events, policy advocacy, and ecosystem services to member biotech companies. Most direct peer to BioSTL in terms of mission (regional bioscience convening/advocacy) and stakeholder mix.
- BioNJ: New Jersey's life sciences trade association serving the state's bioscience industry through advocacy, networking, and educational programming. Direct peer to BioSTL as a regional bioscience industry association with convening and policy functions.
- BioEnterprise / JumpStart Health: Formerly BioEnterprise, JumpStart Health is a Cleveland-based bioscience innovation organization that funds, advises, and accelerates health IT, biotech, and medical device companies in Northeast Ohio. Direct peer to BioSTL/BioGenerator as a regional health-innovation investor and accelerator with a similar Midwest geographic profile.
- Innovation Works: Pittsburgh-based early-stage investor and innovation hub that funds and supports technology and life sciences startups across Southwestern Pennsylvania. Comparable to BioGenerator's role within BioSTL — providing seed/Series A capital and operational support to early-stage science-based startups in a Rust Belt region.
- Activate (formerly Cyclotron Road): Berkeley-based fellowship supporting entrepreneurial scientists translating research into hard-tech and biotech companies. Comparable to BioSTL's Venture Fellows program and BioGenerator's catalytic-capital model for science-based founders.
- Mind the Bridge: San Francisco-based global innovation advisory that runs international soft-landing programs connecting startups from Europe, Israel, and Asia to Silicon Valley. Highly comparable to BioSTL Global's NHS, AgVaya, and ARISE international soft-landing partnerships.
Broad incumbents
- ARCH Venture Partners: One of the largest early-stage biotech venture investors, with a portfolio spanning therapeutics, diagnostics, and biotech platforms. Comparable to BioGenerator's investment function at a vastly larger scale and broader geographic reach.
Others
- Cortex Innovation Community: St. Louis-based innovation district where BioGenerator Labs is headquartered. Adjacent ecosystem partner and physical host of BioSTL's lab infrastructure; not a direct competitor but a co-located community serving similar startups.
- 39 North / BRDG Park: St. Louis agtech innovation district hosting the Helix Center where BioGenerator Labs operates. Adjacent ecosystem player serving the same agtech startups as BioSTL's ag innovation programs but focused on real estate rather than convening/investing.
Market position
Strengths5 records
Weaknesses2 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
BioSTL social profiles
Digital presenceBioSTL financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioSTL leadership team
Management profileNumber of profiles
Profiles11 records
BioSTL subsidiaries and ownership
Company hierarchySubsidiaries2 records
BioSTL funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioSTL M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioSTL
What does BioSTL do?
BioSTL is a 501(c)(3) nonprofit that builds and convenes the St. Louis bioscience innovation ecosystem. Through its investment arm BioGenerator, it provides catalytic early-stage capital, lab space, and company-building resources to life sciences startups in human health and agriculture. It also runs international soft-landing programs (BioSTL Global, Global AgXelerate), workforce training (BIOTECH for MO, Venture Fellows), and convenes flagship annual events (Global Health Innovation Summit, Global AgriFood Innovation Summit, Breakthrough Gala, Startup Connect).
Is BioSTL a public or private company?
BioSTL is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was BioSTL founded?
BioSTL was founded in 2001. It employs 11 to 50 people.
Where is BioSTL based?
BioSTL is headquartered in St Louis, United States, in the North America region.
How does BioSTL make money?
Three revenue lines are on record. Donations and Philanthropic Support is the primary driver. The others are gala and Event Sponsorships and bioGenerator Investment Returns.
Who are BioSTL's main competitors?
Direct peers on record are Biocom, MassBio, BioNJ, BioEnterprise / JumpStart Health, Innovation Works, Activate (formerly Cyclotron Road) and Mind the Bridge. ARCH Venture Partners is listed as a broad incumbent. Others are Cortex Innovation Community and 39 North / BRDG Park.
Does BioSTL have an API?
No public API is recorded for BioSTL.
What industry is BioSTL in?
BioSTL's product category is Bioscience Innovation Ecosystem Development. Its primary akta.pro industry code is EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives, with a secondary code of HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 5417 and its SIC code is 8731.